AP
AGN

AHL Partners’s Allergan plc AGN Stock Holding History

AHL Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$3.3M Sell
20,160
-7,190
-26% -$1.29M 0.05% 589
2017
Q3 		$5.61M Buy
27,350
+14,217
+108% +$3.31M 0.1% 362
2017
Q2 		$3.19M Buy
13,133
+8,484
+182% +$1.99M 0.07% 503
2017
Q1 		$1.11M Buy
4,649
+3,247
+232% +$756K 0.02% 763
2016
Q4 		$294K Buy
1,402
+356
+34% +$73.7K 0.01% 965
2016
Q3 		$241K Buy
1,046
+71
+7% +$17.4K 0.01% 1039
2016
Q2 		$225K Buy
+975
New +$225K 0.01% 769
2016
Q1 		– Sell
-2,477
Closed -$774K – 863
2015
Q4 		$774K Buy
2,477
+1,599
+182% +$476K 0.06% 396
2015
Q3 		$239K Sell
878
-7,061
-89% -$2.17M 0.04% 626
2015
Q2 		$2.41M Sell
7,939
-2,559
-24% -$763K 0.1% 437
2015
Q1 		$3.12M Buy
10,498
+4,044
+63% +$1.15M 0.12% 397
2014
Q4 		$1.66M Buy
+6,454
New +$1.61M 0.09% 511

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

AHL Partners's AGN Position: Q4 2017 in Review

AHL Partners reduced its Allergan plc (AGN) stake by 26% in Q4 2017, selling an estimated $1.29M and leaving 20,160 shares worth $3.3M. The position accounts for 0.05% of the portfolio, ranked #589.

AHL Partners first reported a position in AGN in Q4 2014 and has held it in 12 quarters since. The position peaked at $5.61M in Q3 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • AHL Partners held 20,160 shares of Allergan plc worth $3.3M as of Q4 2017.
  • AHL Partners sold 7,190 Allergan plc shares in Q4 2017, an estimated $1.29M.
  • Allergan plc made up 0.05% of AHL Partners's portfolio in Q4 2017, its #589 holding.
  • AHL Partners first reported a position in Allergan plc in Q4 2014 and has held it in 12 quarters since.
  • AHL Partners's Allergan plc position peaked at $5.61M in Q3 2017.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.